Literature DB >> 16033931

A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City.

Benny J Kottiri1, Samuel R Friedman, Gary L Euler, Peter L Flom, Milagros Sandoval, Alan Neaigus, Don C Des Jarlais, Jonathan M Zenilman.   

Abstract

We conducted a community-based study of the prevalence and correlates of hepatitis B virus (HBV) infection and immunization among young adults in a "drug supermarket" neighborhood in New York City. Four hundred eighty-nine young adults ages 18-24 years were recruited from Bushwick, Brooklyn through multistage household probability sampling (n = 332) and targeted sampling (n = 157), interviewed, and tested for three hepatitis B markers (HBsAg, anti-HBc, and anti-HBs). Serological evidence of HBV infection was found in 8.0% (6.0% in the household sample and 12.1% in the targeted sample) and of hepatitis B immunization in 19.6% (22.6% in the household sample and 13.4% in the targeted sample). HBV infection was higher among young adults who either used crack or injected drugs and among those who traded sex for money or drugs. Having Medicaid was significantly associated with lower odds of infection in the household sample and higher odds of immunization in the targeted sample. Although adolescent hepatitis B immunization has been a public health priority in the United States since 1995, nearly three-quarters of young adults in this community did not have serological evidence of being either exposed or immunized. Whereas subsequent younger generations benefited from universal childhood hepatitis B immunization, this particular cohort of young adults who live in communities like Bushwick presents a unique group for prevention intervention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033931      PMCID: PMC3456058          DOI: 10.1093/jurban/jti095

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  22 in total

1.  Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.

Authors:  D C Des Jarlais; D G Fisher; J C Newman; B N Trubatch; M Yancovitz; D Paone; D Perlman
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

2.  Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study.

Authors:  Paula J Lum; Kristen C Ochoa; Judith A Hahn; Kimberly Page Shafer; Jennifer L Evans; Andrew R Moss
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

Review 3.  A review of the case for hepatitis B vaccination of high-risk adults.

Authors:  Josiah D Rich; Catherine G Ching; Michelle A Lally; Melissa M Gaitanis; Beth Schwartzapfel; Anthony Charuvastra; Curt G Beckwith; Timothy P Flanigan
Journal:  Am J Med       Date:  2003-03       Impact factor: 4.965

4.  Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year-old youth in a high-risk neighborhood.

Authors:  P L Flom; S R Friedman; B J Kottiri; A Neaigus; R Curtis; D C Des Jarlais; M Sandoval; J M Zenilman
Journal:  Sex Transm Dis       Date:  2001-10       Impact factor: 2.830

5.  Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.

Authors:  Ian T Williams; Susan T Goldstein; Joseph Tufa; Sylvia Tauillii; Harold S Margolis; Francis J Mahoney
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

6.  Acceptance of hepatitis B vaccination among adult patients with sexually transmitted diseases.

Authors:  G D Zimet; R Kee; Y Winston; S M Perkins; K Maharry
Journal:  Sex Transm Dis       Date:  2001-11       Impact factor: 2.830

7.  Hepatitis B prevalence in young women living in low-income areas: the population-based San Francisco Bay area's Young Women's Survey.

Authors:  M T Hernandez; J D Klausner; W McFarland; E Wong; G Bolan; F Molitor; J D Ruiz
Journal:  Sex Transm Dis       Date:  2000-10       Impact factor: 2.830

8.  Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood.

Authors:  S R Friedman; P L Flom; B J Kottiri; A Neaigus; M Sandoval; R Curtis; J M Zenilman; D C Des Jarlais
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

9.  Hepatitis B vaccination for sex workers: do outreach programmes perform better?

Authors:  R Mak; A Traen; M Claeyssens; L Van Renterghem; G Leroux-Roels; P Van Damme
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

10.  Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals.

Authors:  Rajesh T Gandhi; Alysse Wurcel; Hang Lee; Barbara McGovern; Melinda Boczanowski; Roslyn Gerwin; Colleen P Corcoran; Zbigniew Szczepiorkowski; Sarah Toner; Daniel E Cohen; Paul E Sax; Chinweike Ukomadu
Journal:  Clin Infect Dis       Date:  2003-06-06       Impact factor: 9.079

View more
  4 in total

1.  Sampling and recruitment in multilevel studies among marginalized urban populations: the IMPACT studies.

Authors:  Danielle C Ompad; Sandro Galea; Grant Marshall; Crystal M Fuller; Linda Weiss; John R Beard; Christina Chan; Vincent Edwards; David Vlahov
Journal:  J Urban Health       Date:  2008-01-24       Impact factor: 3.671

2.  Prevalence and correlates of previous hepatitis B vaccination and infection among young drug-users in New York City.

Authors:  S Amesty; D C Ompad; S Galea; C M Fuller; Y Wu; B Koblin; D Vlahov
Journal:  J Community Health       Date:  2008-06

3.  Low rates of hepatitis B virus screening at the onset of chemotherapy.

Authors:  Jessica P Hwang; Michael J Fisch; Hong Zhang; Michael A Kallen; Mark J Routbort; Lincy S Lal; John M Vierling; Maria E Suarez-Almazor
Journal:  J Oncol Pract       Date:  2012-06-12       Impact factor: 3.840

4.  Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection.

Authors:  Samuel R Friedman; Pedro Mateu-Gelabert; Milagros Sandoval; Holly Hagan; Don C Des Jarlais
Journal:  BMC Public Health       Date:  2008-03-20       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.